Concepedia

Pierangela Sepe

PS

13

Publications

337

Citations

11

H-Index

2018

Active since

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

University of Parma

Istituto Oncologico Veneto

Pierangela Sepe is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in urology, medicine, and oncology.

ORCID

Top concepts

Publications per year

2018–2022

13

Publications

13

Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma

Giuseppe Procopio, Pierangela Sepe, Mélanie Claps et al. · JAMA Oncology · 2022 · 57 citations · Full text

A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro trial 03)

Giuseppe Procopio, Mélanie Claps, Chiara Pircher et al. · Tumori Journal · 2022 · 46 citations · Full text

Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression

Vera Cappelletti, Elena Verzoni, Raffaele Ratta et al. · International Journal of Molecular Sciences · 2020 · 45 citations · Full text

, , +20

Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis

Roberto Iacovelli, Chiara Ciccarese, Gaetano Facchini et al. · Targeted Oncology · 2020 · 39 citations · Full text

, , +5

Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors

Matteo Santoni, Daniel Y.C. Heng, Sergio Bracarda et al. · Cancers · 2019 · 31 citations · Full text

Rows per page

1–5 of 13